Tag: side effects
-
Padcev Skin Reaction Side Effects SJS and TEN: From No Warning to “Black Box” in Less Than 2 Years
Bladder Cancer Drug Padcev is Linked to Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) in 2021 (Posted by Tom Lamb at Drug Injury Watch) Padcev (enfortumab vedotin-ejfv), an injection drug for intravenous use, was…
-
Xeljanz: FDA Warnings Updated: There are Higher Rates of Blood Clots and Deaths for Both Doses of Xeljanz, Now
JAK Inhibitors Xeljanz, Olumiant, and Rinvoq Get Drug Label Changes and Drug Use Limitations in September 2021 (Posted by Tom Lamb at Drug Injury Watch) On September 1, 2021, the FDA released this alerting news…
-
Invokana, Farxiga, Jardiance, Other SGLT2 Inhibitors Associated With Retinal Vein Occlusion
Increased Risk for This New Vision/Eyes Side Effect Highest in Elderly Patients and Chronic Kidney Disease Patients (Posted by Tom Lamb at Drug Injury Watch) In June 2021 it was reported that Invokana, Farxiga, and…
-
Elmiron Pigmentary Maculopathy Risk Warning Issued by Janssen and Health Canada in December 2020
New Medical Article Describes How to Identify, Image, and Diagnose Pigmentary Maculopathy Caused by Elmiron Use (Posted by Tom Lamb at Drug Injury Watch) On December 15, 2020 a Dear Healthcare Professional…
-
Novartis Update on Patients Suffering from Retinal Vasculitis and/or Retinal Vascular Occlusion After Beovu Injections
November 2020 Report: Beovu Eye Side Effects Risks Higher for Beovu Patients with Prior Intraocular Inflammation and/or Vascular Occlusion (Posted by Tom Lamb at DrugInjuryWatch.com) We have known since early 2020 that…
-
Picato Recalls Continue with Canada and Denmark Being Most Recent, All Due to Risk of Skin Cancer
A Global Phase-out of Picato Sales by LEO Pharma Inc. Due to this Picato Safety Finding Expected by End of 2020 (Posted by Tom Lamb at DrugInjuryWatch.com) But first, we get…
-
Ocaliva FDA Adverse Events Reports for Hepatobiliary System Cases: An Analysis as of October 2020
Lack of Warnings in Current Ocaliva Drug Label for Some Serious Side Effects Involving Liver, Gallbladder, Bile Ducts (Posted by Tom Lamb at DrugInjuryWatch.com) We are still wondering how the current FDA…
-
Potential Ocaliva – Liver Disorder Safety Signal Being Investigated by FDA as Side Effects Risk
October 2020 News Report Reveals "New" Ocaliva Liver Safety Issue, Which Had Been Under the Radar Previously (Posted by Tom Lamb at DrugInjuryWatch.com) Ocaliva (obeticholic acid) was approved by the FDA in…
-
Drug Safety Issue: Elmiron Side Effects Risks for Eye and Vision Appear to be Greater Than Bladder Treatment Benefits
Patients Consider Whether Relief from Bladder Pain is Worth Possibility of Elmiron-Associated Maculopathy and Other Eye Problems (Posted by Tom Lamb at DrugInjuryWatch.com) Approved by the FDA way back in 1996, Elmiron…